KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Repligen (RGEN) EBITDA Margin (2016 - 2025)

Historic EBITDA Margin for Repligen (RGEN) over the last 16 years, with Q3 2025 value amounting to 6.63%.

  • Repligen's EBITDA Margin rose 7100.0% to 6.63% in Q3 2025 from the same period last year, while for Sep 2025 it was 4.56%, marking a year-over-year increase of 44500.0%. This contributed to the annual value of 6.34% for FY2024, which is 114300.0% down from last year.
  • As of Q3 2025, Repligen's EBITDA Margin stood at 6.63%, which was up 7100.0% from 33.44% recorded in Q2 2025.
  • In the past 5 years, Repligen's EBITDA Margin ranged from a high of 37.26% in Q4 2022 and a low of 30.9% during Q4 2024
  • Moreover, its 5-year median value for EBITDA Margin was 11.08% (2022), whereas its average is 10.25%.
  • In the last 5 years, Repligen's EBITDA Margin tumbled by -438000bps in 2023 and then skyrocketed by 307900bps in 2025.
  • Repligen's EBITDA Margin (Quarter) stood at 11.87% in 2021, then skyrocketed by 214bps to 37.26% in 2022, then tumbled by -118bps to 6.54% in 2023, then crashed by -373bps to 30.9% in 2024, then soared by 121bps to 6.63% in 2025.
  • Its EBITDA Margin was 6.63% in Q3 2025, compared to 33.44% in Q2 2025 and 6.22% in Q1 2025.